Acumen Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ABOS
CUSIP
00509G209
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00509G209 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
29.5% 3/17/2026
Event 3/13/2026
Sands Capital Alternatives, LLC 13G/A
5.6% 8/13/2025
Event 6/30/2025
James B. Murray Jr. 13G 5.0% 4/7/2026
Event 4/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Franklin Resources, Inc. 13G/A
3.8% 11/4/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 96 48.6 M $103M
2026 Q2 96 47.9 M $128M
2026 Q1 85 46.0 M $109M
2025 Q4 71 35.7 M $75.2M
2025 Q3 69 35.7 M $61.1M
2025 Q2 73 37.6 M $43.6M
2025 Q1 83 40.3 M $44.8M
2024 Q4 81 42.5 M $73.2M
2024 Q3 74 43.6 M $108M
2024 Q2 83 43.6 M $105M
2024 Q1 82 43.4 M $176M
2023 Q4 68 38.4 M $148M
2023 Q3 67 43.2 M $179M
2023 Q2 55 26.3 M $127M
2023 Q1 63 27.8 M $113M
2022 Q4 63 28.8 M $155M
2022 Q3 53 27.8 M $278M
2022 Q2 48 25.6 M $120M
2022 Q1 58 27.1 M $106M
2021 Q4 53 25.6 M $173M
2021 Q3 42 24.1 M $357M